HK1207984A1 - Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases - Google Patents

Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases

Info

Publication number
HK1207984A1
HK1207984A1 HK15108693.6A HK15108693A HK1207984A1 HK 1207984 A1 HK1207984 A1 HK 1207984A1 HK 15108693 A HK15108693 A HK 15108693A HK 1207984 A1 HK1207984 A1 HK 1207984A1
Authority
HK
Hong Kong
Prior art keywords
brain
veliparib
treatment
combination
radiation therapy
Prior art date
Application number
HK15108693.6A
Other languages
English (en)
Chinese (zh)
Inventor
Vincent L Giranda
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48576528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1207984(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of HK1207984A1 publication Critical patent/HK1207984A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15108693.6A 2012-05-15 2015-09-07 Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases HK1207984A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261647329P 2012-05-15 2012-05-15
PCT/US2013/041095 WO2013173428A1 (en) 2012-05-15 2013-05-15 Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases

Publications (1)

Publication Number Publication Date
HK1207984A1 true HK1207984A1 (en) 2016-02-19

Family

ID=48576528

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108693.6A HK1207984A1 (en) 2012-05-15 2015-09-07 Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases

Country Status (18)

Country Link
US (1) US20130310625A1 (es)
EP (1) EP2849750A1 (es)
JP (1) JP2015521188A (es)
KR (1) KR20150017355A (es)
CN (1) CN104602688A (es)
AU (1) AU2013262906A1 (es)
BR (1) BR112014028618A2 (es)
CA (1) CA2873119A1 (es)
CL (1) CL2014003072A1 (es)
DO (1) DOP2014000258A (es)
HK (1) HK1207984A1 (es)
IL (1) IL235389A0 (es)
MX (1) MX2014013903A (es)
PH (1) PH12014502464A1 (es)
RU (1) RU2014150506A (es)
SG (1) SG11201407498RA (es)
TW (1) TW201400113A (es)
WO (1) WO2013173428A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9623009B2 (en) * 2014-09-16 2017-04-18 Abbvie, Inc. Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI375673B (en) 2005-04-11 2012-11-01 Abbott Lab 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
PL2338487T3 (pl) 2006-01-17 2014-03-31 Abbvie Bahamas Ltd Terapia skojarzona z inhibitorami PARP
WO2011130689A1 (en) * 2010-04-15 2011-10-20 Tracon Pharmaceuticals, Inc. Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors

Also Published As

Publication number Publication date
EP2849750A1 (en) 2015-03-25
SG11201407498RA (en) 2014-12-30
CA2873119A1 (en) 2013-11-21
PH12014502464A1 (en) 2014-12-22
CL2014003072A1 (es) 2015-02-27
IL235389A0 (en) 2014-12-31
CN104602688A (zh) 2015-05-06
RU2014150506A (ru) 2016-07-10
MX2014013903A (es) 2015-01-16
DOP2014000258A (es) 2015-01-15
WO2013173428A1 (en) 2013-11-21
AU2013262906A1 (en) 2014-11-20
JP2015521188A (ja) 2015-07-27
US20130310625A1 (en) 2013-11-21
BR112014028618A2 (pt) 2017-06-27
TW201400113A (zh) 2014-01-01
KR20150017355A (ko) 2015-02-16

Similar Documents

Publication Publication Date Title
IL289300A (en) Combined treatment for cancer
HRP20190046T1 (hr) Kombinirana terapija za liječenje raka
HK1203977A1 (en) Enhancement of transport of therapeutic molecules across the blood brain barrier
SI3033086T1 (sl) Kombinirana terapija za zdravljenje raka
IL263661A (en) Combination therapy for the treatment of glioblastoma
EP2830633A4 (en) COMBINATION THERAPY FOR CANCER TREATMENT
HK1207013A1 (en) Catheter for photodynamic therapy
PT2872176T (pt) Carboranilporpirinas para utilização no tratamento de cancro
IL236321A0 (en) Combined treatment for cancer and immunosuppression
HK1207984A1 (en) Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases
IL233495A0 (en) Combination for cancer treatment
HK1209111A1 (zh) 醌系化合物及其用於癌症治療的用途
GB201222544D0 (en) Photodynamic therapy and diagnosis
GB201309337D0 (en) Photodynamic Therapy and Diagnosis